4611 - 4620 of 9145 Results
Title
Year
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 41
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 39
-
OPENTitle: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageJournal Name: eBioMedicinePublisher: Elsevier BVVol: 82Issue #:Start Page: 104179End Page: 104179Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104179Best OA location URL: http://www.thelancet.com/article/S2352396422003607/pdfCitation Count: 59
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase InhibitorsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 18Issue #: 4Start Page: 810End Page: 821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.2c00868Best OA location URL: https://doi.org/10.1021/acschembio.2c00868Citation Count: 20
-
OPENTitle: Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson’s diseaseJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 200End Page: 200Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-025-02227-2Best OA location URL: https://doi.org/10.1186/s40168-025-02227-2Citation Count: 6
-
OPENTitle: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's diseaseJournal Name: The Journal of PathologyPublisher: WileyVol: 243Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/path.4929Best OA location URL: http://doi.org/10.1002/path.4929Citation Count: 141
- Conversational analysis of consciousness during seizures2020RESTRICTEDTitle: Conversational analysis of consciousness during seizuresJournal Name: Epilepsy & BehaviorPublisher: Elsevier BVVol: 112Issue #:Start Page: 107486End Page: 107486Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.yebeh.2020.107486Citation Count: 4
-
OPENTitle: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial designJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 22Issue #:Start Page: 100785End Page: 100785Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100785Citation Count: 17
-
OPENTitle: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 4Start Page: 479End Page: 483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13451Citation Count: 29